Against all odds, Gottstein exposed the deception of a pharmaceutical giant and saved thousands of lives The Zyprexa Papers by Jim Gottstein A review by David Antonuccio, University of Nevada To me, The Zyprexa Papers reads like a combination between a Stephen King horror tale and a John Grisham legal thriller. I have met the […]
CounterPunch.org has just published a great review of The Zyprexa Papers, Jim Gottstein’s book about his battle over Zyprexa (Olanzapine) with drug marketing giant Eli Lilly. Written by Bruce E. Levine, a psychologist and social critic, the review addresses the broad social issues raised by Jim Gottstein’s story. “The Zyprexa Papers is not simply about the harm done by blockbuster psychiatric drugs and drug company illegal marketing. It is also about the perversion of the U.S. legal system, as Gottstein illuminates the courts’ use of secrecy orders in settlement agreements to the detriment of the public.”
The Zyprexa Papers has two interlocking parts. One centers on a set of documents relating to Eli Lilly’s Zyprexa (olanzapine), a company cash cow, which had been made available under a secrecy order to lawyers acting for hundreds of people injured by Zyprexa. The other centres on Bill Bigley, a man enmeshed in the Alaskan mental health system since the early 1980s with over 70 admissions.
If you start reading, be warned, all of your defences will be stripped away. If you think what happens to Bill Bigley could only happen in some out of way place, like Anchorage, think again… It takes a certain amount of time and distance to write a book as good as this. It also takes a certain amount of nerve. It is likely that no conventional publisher would take a risk on publishing this. All the more reason to buy The Zyprexa Papers.